Avaí Bio, Inc. (AVAI)
OTCMKTS
· Delayed Price · Currency is USD
0.360
-0.020 (-5.26%)
Mar 5, 2026, 3:30 PM EST
Avaí Bio Company Description
Avaí Bio, Inc. acquires, creates, and develops artificial intelligence (AI) technologies.
It also offers information technology (IT) consulting services. The company provides full-stack software development, database management, data integration, project management and cloud services resources.
Further, it offers Avant! AI, a platform that has shown impressive results related to the technology’s usage, access, and performance; and InstantFAME.
The company was formerly known as Avant Technologies Inc. and changed its name to Avaí Bio, Inc. in February 2026.
Avaí Bio, Inc. was incorporated in 2017 and is based in Vilnius, Lithuania.
Avaí Bio, Inc.
| Country | United States |
| Founded | 2017 |
| Industry | Software - Application |
| Sector | Technology |
| CEO | Chris Winter |
Contact Details
Address: Sv. Stepono g. 27D-2 Vilnius, Nevada Nevada Lithuania | |
| Phone | 866 533 0065 |
| Website | avaibio.com |
Stock Details
| Ticker Symbol | AVAI |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | US89487B1008 |
| SIC Code | 7370 |
Key Executives
| Name | Position |
|---|---|
| Chris Winter | Chief Executive Officer |
| Ivan Lunegov | President and Director |
| Vitalis Racius | Chief Financial Officer, Director and Treasurer |
| Natalija Tunevic | Secretary |